167 related articles for article (PubMed ID: 36388685)
1. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer.
Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D
J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
3. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Lin G; Wang H; Wu Y; Wang K; Li G
Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
[No Abstract] [Full Text] [Related]
4. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.
Jiang F; Chen X; Shen Y; Shen X
Front Genet; 2022; 13():891744. PubMed ID: 35928449
[No Abstract] [Full Text] [Related]
6. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Li Z; Li F; Peng Y; Fang J; Zhou J
Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
[TBL] [Abstract][Full Text] [Related]
7. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
8. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
9. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
Wang JM; Li X; Yang P; Geng WB; Wang XY
BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
12. Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients.
Huang X; Wang HF; Huang S
Front Genet; 2022; 13():906880. PubMed ID: 36061188
[No Abstract] [Full Text] [Related]
13. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer.
Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H
Front Genet; 2022; 13():957655. PubMed ID: 36105100
[No Abstract] [Full Text] [Related]
18. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15.
Yue L; Zhang R; Chen S; Duan G
Front Cell Dev Biol; 2022; 10():710708. PubMed ID: 35433701
[No Abstract] [Full Text] [Related]
19. Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients.
Zhou L; Chen Z; Wu Y; Lu H; Xin L
Cancer Cell Int; 2021 Jul; 21(1):357. PubMed ID: 34233659
[TBL] [Abstract][Full Text] [Related]
20. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
